Executive team

Agustin Fernandez


Chief Executive Officer

David Brindley, DPhil, MEng; PG Cert, (IP), RAC (US), FRSA, FRSB


Chief Regulatory & IP Officer

Edward Gershburg, PhD


Chief Technology Officer

Luis Rios-Nogales, MD, PhD, MBA


Chief Development and Medical Officer

Aziz Friedrich


Chief Financial Officer & Vice President of Operations

Gerhard Hager, PhD


Head of Non-Clinical Development

Kerstin Westritschnig, MD


Head of Clinical Development

Konstantin Kousoulas PhD


VP of Scientific Affairs

Cecilia Huaman, MPH, Ph.D


Director Immunology and Diagnostics

Brandie Murphy


Lab Manager

Bob Lemon, B.S., MBA


CMC Project Manager

Quinn Steele


Head of GxP and Regulatory E-Systems

Diane Abbitt, Esq


Patient Advocate

Christy Mazzarisi


Vice President, Corporate Quality

Scientific Advisory Board

Paul Predki, PhD


SAB Chair, Biotech executive, co-founder and CTO of Iridia Inc.

Rahul Singhvi, ScD, MBA


Operating Partner, Flagship Pioneering

Lional Raj, MD


Medical Director, Department of Cornea and Refractive Surgery, Dr. Agarwal’s Eye Hospital, India

Georg Holländer, MA, MD, FMedSci, FRCPCH, FHM Pediatrics


Chair, Department of Pediatrics, University of Oxford, Oxford, UK

Todd Margolis, MD, PhD


Chair, Department of Ophthalmology, Washington University, St. Louis, MO, USA

Jim Robinson, BS, MS


Industry Consultant

David I. Bernstein, MD, MA


Professor of Pediatric Infectious Diseases at Cincinnati Children’s Hospital Medical Center

Stanley A. Plotkin, MD


Emeritus Professor at the University of Pennsylvania

Alan Kimura, MD, PhD


SVP & Therapeutic Area Head for Rare Diseases at CureVac